Comparative genomic hybridization (CGH)

• US 5,665,549 A
• Filed: 06/06/1995
• Issued: 09/09/1997
• Est. Priority Date: 03/04/1992
• Status: Expired due to Term

• Current Assignee: Regents of the University of California (University of California)
• Original Assignee: Regents of the University of California (University of California)
• Inventors: Waldman, Frederic, Pinkel, Daniel, Gray, Joe W., Kallioniemi, Anne, Kallioniemi, Olli-Pekka
• Primary Examiner(s): Elliott, George C.
• Assistant Examiner(s): FREDMAN, JEFFREY NORMAN
• Application Number:
  US08/466,122
• Time in Patent Office: 826 Days
• Field of Search: 435/6, 435/91.2, 536/22.1, 536/23.1, 536/24.3, 536/24.31, 536/24.32, 536/24.33
• US Class Current: 435/6.14
• CPC Class Codes: C12Q 1/6809 Methods for determination or identification of nucleic acids involving differential detection
• CPC Class Codes: C12Q 1/6841 In situ hybridisation
• CPC Class Codes: C12Q 1/6853 using modified primers or templates
• CPC Class Codes: C12Q 1/6886 for cancer immunoassay for cancer G01N33/574
• CPC Class Codes: C12Q 2525/151 repeat or repeated sequences, e.g. VNTR, microsatellite, concatemer
• CPC Class Codes: C12Q 2537/143 Multiplexing, i.e. use of multiple primers or probes in a single reaction, usually for simultaneously analyse of multiple analysis
• CPC Class Codes: C12Q 2545/113 with an external standard/control, i.e. control reaction is separated from the test/target reaction
• CPC Class Codes: C12Q 2545/114 involving a quantitation step
• CPC Class Codes: C12Q 2563/107 fluorescence
• CPC Class Codes: C12Q 2600/158 Expression markers

Abstract

Disclosed are new methods comprising the use of in situ hybridization to detect abnormal nucleic acid sequence copy numbers in one or more genomes wherein repetitive sequences that bind to multiple loci in a reference chromosome spread are either substantially removed and/or their hybridization signals suppressed. The invention termed Comparative Genomic Hybridization (CGH) provides for methods of determining the relative number of copies of nucleic acid sequences in one or more subject genomes or portions thereof (for example, a tumor cell) as a function of the location of those sequences in a reference genome (for example, a normal human genome). The intensity(ies) of the signals from each labeled subject nucleic acid and/or the differences in the ratios between different signals from the labeled subject nucleic acid sequences are compared to determine the relative copy numbers of the nucleic acid sequences in the one or more subject genomes as a function of position along the reference chromosome spread. Amplifications, duplications and/or deletions in the subject genome(s) can be detected. Also provided is a method of determining the absolute copy numbers of substantially all RNA or DNA sequences in subject cell(s) or cell population(s).

Claims

1. A method of comparing copy numbers of unique DNA sequences in a first cell or cell population relative to copy numbers of substantially identical sequences in a second cell or cell population, said method comprising the steps of:

(a) labelling genomic DNA sequences from each cell or cell population with a different label;

(b) hybridizing said labelled DNA sequences from each cell or cell population to a reference genome under the following conditions;

(i) either the labelled DNA sequences, andr the reference genome have their repetitive sequences blocked and/or removed; and

(ii) unique DNA sequences in the labelled DNA sequences and unique DNA sequences in the reference genome are retained;

(c) comparing the intensities of the signals from the labelled DNA sequences hybridized to the reference genome.

2. The method of claim 1, wherein the reference genome comprises at least one metaphase chromosome.

3. The method of claim 1, wherein the DNA sequences are isolated from tumor cells.

4. The method of claim 1, wherein the DNA sequences are isolated from fetal cells.

5. The method of claim 1, wherein the DNA is chromosomal DNA or cDNA.

6. The method of claim 1, wherein the reference genome is an antenna cell line.

7. The method of claim 1, further comprising the step of amplifying the DNA sequences from at least one of said first cell or cell population and said second cell or cell population prior to said hybridizing step.

8. The method of claim 1, wherein the labelled DNA is directly visualizable.

9. The method of claim 1, further comprising rendering the bound, labelled DNA visualizable after said hybridization step.

10. The method of claim 1, wherein blocking of the repetitive sequences is carried out by including unlabelled copies of the repetitive sequences with said labelled DNA sequences.

11. The method according to claim 1, wherein said cell or cell population is derived from a clinical specimen.

12. The method according to claim 1, wherein the hybridization is done in situ, the reference genome comprises reference metaphase chromosomes, and the intensities of signals from labeled nucleic acid sequences are compared as a function of position in the reference genome.

13. The method according to claim 1, wherein the labelled DNA sequences are hybridized to a portion of the reference genome.

14. The method according to claim 1, wherein said first cell or cell population and said second cell or cell populations and said reference genome are from the same species.

15. The method according to claim 1, wherein the reference genome is human.

16. The method according to claim 1, wherein said labelled nucleic acid sequences are labelled with fluorescers, ligands, chemiluminescers, enzyme substrates, enzyme co-factors, particles or dyes.

17. The method according to claim 1, which method further comprises extracting the DNA comprising the nucleic acid sequences from said first cell or cell population and said second cell or cell population from formalin-fixed and/or paraffin-embedded archived tissue specimens prior to labelling.

18. The method according to claim 1, wherein the step of comparing the intensities of the signals from the labelled DNA sequences comprises determining the ratio of the intensities of the signals as a function of position in the reference genome, said method further comprising quantitatively comparing the intensity ratio among different locations along the reference genome, said ratio at each location being proportional to the ratio of the copy number of the nucleic acid sequence that binds to that location in the first cell or cell population to the copy number of a substantially identical sequence in the second cell or cell population.

19. The method according to claim 1, wherein one of the cells or cell populations is a test cell or cell population and the other is a normal cell or cell population.

20. The method according to claim 1, further comprising employing chromosome-specific painting, fluorescence in situ hybridization, Northern analysis or Southern analysis to determine absolute copy number of the unique DNA sequences throughout the genome.

21. The method according to claim 1, wherein the copy number of unique DNA sequences in more than two cells or cell populations is compared.

22. A method of comparing copy numbers of unique DNA sequences in a first cell or cell population relative to copy numbers of substantially identical sequences in a second cell or cell population, said method comprising the steps of:

(a) labelling genomic DNA sequences from each cell or cell population with a different fluorochrome label;

(b) hybridizing, in situ, said labelled DNA sequences from each cell or cell population to a reference genome under the following conditions;

(i) either the labelled DNA sequences, and/or the reference genome have their repetitive sequences blocked and/or removed; and

(ii) unique DNA sequences in the labelled DNA sequences and unique DNA sequences in the reference genome are retained;

(c) comparing the intensities of the signals from the fluorochrome labelled DNA sequences hybridized to the reference genome.

23. The method of claim 22, wherein the reference genome comprises metaphase chromosomes.

24. The method according to claim 22, wherein the reference genome comprises reference metaphase chromosomes, and the intensities of signals from labeled DNA sequences are compared as a function of position in the reference genome.

25. The method according to claim 22, wherein the step of comparing the intensities of the signals from the labelled DNA sequences comprises determining the ratio of the intensities of the signals as a function of position in the reference genome.

26. The method according to claim 25, further comprising quantitatively comparing the intensity ratio among different locations along the reference genome, said ratio at each location being proportional to the ratio of the copy number of the DNA sequence that binds to that location in the first cell or cell population to the copy number of a substantially identical DNA sequence in the second cell or cell population.

27. The method according to claim 22, wherein the copy number of unique DNA sequences in more than two cells or cell populations is compared.

28. A method of comparing copy numbers of unique RNA sequences in a first cell or cell population relative to copy numbers of substantially identical sequences in a second cell or cell population, said method comprising the steps of:

(a) labelling RNA sequences from each cell or cell population with a different label;

(b) hybridizing said labelled RNA sequences from each cell or cell population to a reference genome under the following conditions;

(i) either the labelled RNA sequences, and/or the reference genome have their repetitive sequences blocked and/or removed; and

(ii) unique RNA sequences in the labelled RNA sequences and unique RNA sequences in the reference genome are retained;

(c) comparing the intensities of the signals from the labelled RNA sequences hybridized to the reference genome.

29. The method of claim 28, wherein the reference genome comprises at least one metaphase chromosome.

30. The method of claim 28, wherein the RNA sequences are isolated from tumor cells.

31. The method of claim 28, wherein the RNA sequences are isolated from fetal cells.

32. The method of claim 28, wherein the RNA is messenger RNA or mRNA.

33. The method of claim 28, wherein the reference genome is an antenna cell line.

34. The method of claim 28, further comprising the step of amplifying the RNA sequences from at least one of said first cell or cell population and said second cell or cell population prior to said hybridizing step.

35. The method of claim 28, wherein the labelled RNA is directly visualizable.

36. The method of claim 28, further comprising rendering the bound, labelled RNA visualizable after said hybridization step.

37. The method of claim 28, wherein blocking of the repetitive sequences is carried out by including unlabelled copies of the repetitive sequences with said labelled RNA sequences.

38. The method according to claim 28, wherein said cell or cell population is derived from a clinical specimen.

39. The method according to claim 28, wherein the hybridization is done in situ, the reference genome comprises reference metaphase chromosomes, and the intensities of signals from labeled nucleic acid sequences are compared as a function of position in the reference genome.

40. The method according to claim 28, wherein the labelled RNA sequences are hybridized to a portion of the reference genome.

41. The method according to claim 28, wherein said first cell or cell population and said second cell or cell populations and said reference genome are from the same species.

42. The method according to claim 28, wherein the reference genome is human.

43. The method according to claim 28, wherein said labelled nucleic acid sequences are labelled with fluorescers, ligands, chemiluminescers, enzyme substrates, enzyme co-factors, particles or dyes.

44. The method according to claim 28, which method further comprises extracting the RNA comprising the nucleic acid sequences from said first cell or cell population and said second cell or cell population from formalin-fixed and/or paraffin-embedded archived tissue specimens prior to labelling.

45. The method according to claim 28, wherein the step of comparing the intensities of the signals from the labelled RNA sequences comprises determining the ratio of the intensities of the signals as a function of position in the reference genome, said method further comprising quantitatively comparing the intensity ratio among different locations along the reference genome, said ratio at each location being proportional to the ratio of the copy number of the nucleic acid sequence that binds to that location in the first cell or cell population to the copy number of a substantially identical sequence in the second cell or cell population.

46. The method according to claim 28, wherein one of the cells or cell populations is the test cell or cell population and the other is a normal cell or cell population.

47. The method according to claim 28, further comprising employing chromosome-specific painting, fluorescence in situ hybridization, Northern analysis or Southern analysis to determine absolute copy number of the unique RNA sequences throughout the genome.

48. The method according to claim 28, wherein the copy number of unique RNA sequences in more than two cells or cell populations is compared.

49. A method of comparing copy numbers of unique RNA sequences in a first cell or cell population relative to copy numbers of substantially identical sequences in a second cell or cell population, said method comprising the steps of:

(a) labelling RNA sequences from each cell or cell population with a different fluorochrome label;

(b) hybridizing, in situ, said labelled RNA sequences from each cell or cell population to a reference genome under the following conditions;

(i) either the labelled RNA sequences, and/or the reference genome have their repetitive sequences blocked and/or removed; and

(ii) unique RNA sequences in the labelled RNA sequences and unique RNA sequences in the reference genome are retained;

(c) comparing the intensities of the signals from the fluorochrome labelled RNA sequences hybridized to the reference genome.

50. The method of claim 49, wherein the reference genome comprises metaphase chromosomes.

51. The method according to claim 49, wherein the reference genome comprises reference metaphase chromosomes, and the intensities of signals from labeled RNA sequences are compared as a function of position in the reference genome.

52. The method according to claim 49, wherein the step of comparing the intensities of the signals from the labelled RNA sequences comprises determining the ratio of the intensities of the signals as a function of position in the reference genome.

53. The method according to claim 52, further comprising quantitatively comparing the intensity ratio among different locations along the reference genome, said ratio at each location being proportional to the ratio of the copy number of the RNA sequence that binds to that location in the first cell or cell population to the copy number of a substantially identical DNA sequence in the second cell or cell population.

54. The method according to claim 49, wherein the copy number of unique RNA sequences in more than two cells or cell populations is compared.